Literature DB >> 31239059

A click chemistry assay to identify natural product ligands for pre-microRNAs.

Amanda L Garner1, Daniel A Lorenz2, Erin E Gallagher3.   

Abstract

Despite the great diversity of structure and function and relevance to human health, RNA remains an underexploited area of drug discovery. A major bottleneck toward this goal has been the identification of probes and drug leads that are specific for select RNAs and methods that will facilitate such discovery efforts. Our laboratory has recently developed an innovative approach for assaying RNA-small molecule interactions, catalytic enzyme-linked click chemistry assay or cat-ELCCA, which is a functional assay that takes advantage of the power of catalytic signal amplification combined with the selectivity and bioorthogonality of click chemistry. Importantly, through application of this platform assay technology to the challenging problem of identifying selective inhibitors of pre-microRNA maturation, we identified natural products as a potential source of such compounds. Herein we describe this methodology in addition to the downstream pipeline toward the discovery of natural product ligands for pre-microRNAs. Through cat-ELCCA, our goal is to discover novel ligands to facilitate our investigation of RNA recognition by small molecules.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Click chemistry; Dicer; Drug discovery; High-throughput screening; MicroRNAs; Natural products

Year:  2019        PMID: 31239059      PMCID: PMC6631307          DOI: 10.1016/bs.mie.2019.04.020

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  20 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  Selective small-molecule inhibition of an RNA structural element.

Authors:  John A Howe; Hao Wang; Thierry O Fischmann; Carl J Balibar; Li Xiao; Andrew M Galgoci; Juliana C Malinverni; Todd Mayhood; Artjohn Villafania; Ali Nahvi; Nicholas Murgolo; Christopher M Barbieri; Paul A Mann; Donna Carr; Ellen Xia; Paul Zuck; Dan Riley; Ronald E Painter; Scott S Walker; Brad Sherborne; Reynalda de Jesus; Weidong Pan; Michael A Plotkin; Jin Wu; Diane Rindgen; John Cummings; Charles G Garlisi; Rumin Zhang; Payal R Sheth; Charles J Gill; Haifeng Tang; Terry Roemer
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

Review 3.  Natural products as sources of new drugs over the 30 years from 1981 to 2010.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2012-02-08       Impact factor: 4.050

Review 4.  Targeting RNA with small molecules.

Authors:  Jason R Thomas; Paul J Hergenrother
Journal:  Chem Rev       Date:  2008-03-25       Impact factor: 60.622

5.  cat-ELCCA: catalyzing drug discovery through click chemistry.

Authors:  Amanda L Garner
Journal:  Chem Commun (Camb)       Date:  2018-06-19       Impact factor: 6.222

6.  In vitro reconstitution of the human RISC-loading complex.

Authors:  Ian J MacRae; Enbo Ma; Min Zhou; Carol V Robinson; Jennifer A Doudna
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

7.  Development and Implementation of an HTS-Compatible Assay for the Discovery of Selective Small-Molecule Ligands for Pre-microRNAs.

Authors:  Daniel A Lorenz; Steve Vander Roest; Martha J Larsen; Amanda L Garner
Journal:  SLAS Discov       Date:  2017-07-07       Impact factor: 3.341

Review 8.  The Emerging Role of RNA as a Therapeutic Target for Small Molecules.

Authors:  Colleen M Connelly; Michelle H Moon; John S Schneekloth
Journal:  Cell Chem Biol       Date:  2016-09-01       Impact factor: 8.116

9.  Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers.

Authors:  Manaswini Sivaramakrishnan; Kathleen D McCarthy; Sébastien Campagne; Sylwia Huber; Sonja Meier; Angélique Augustin; Tobias Heckel; Hélène Meistermann; Melanie N Hug; Pascale Birrer; Ahmed Moursy; Sarah Khawaja; Roland Schmucki; Nikos Berntenis; Nicolas Giroud; Sabrina Golling; Manuel Tzouros; Balazs Banfai; Gonzalo Duran-Pacheco; Jens Lamerz; Ying Hsiu Liu; Thomas Luebbers; Hasane Ratni; Martin Ebeling; Antoine Cléry; Sergey Paushkin; Adrian R Krainer; Frédéric H-T Allain; Friedrich Metzger
Journal:  Nat Commun       Date:  2017-11-14       Impact factor: 14.919

10.  Expansion of cat-ELCCA for the Discovery of Small Molecule Inhibitors of the Pre-let-7-Lin28 RNA-Protein Interaction.

Authors:  Daniel A Lorenz; Tanpreet Kaur; Samuel A Kerk; Erin E Gallagher; Jorge Sandoval; Amanda L Garner
Journal:  ACS Med Chem Lett       Date:  2018-05-16       Impact factor: 4.345

View more
  2 in total

Review 1.  Design of small molecules targeting RNA structure from sequence.

Authors:  Andrei Ursu; Jessica L Childs-Disney; Ryan J Andrews; Collin A O'Leary; Samantha M Meyer; Alicia J Angelbello; Walter N Moss; Matthew D Disney
Journal:  Chem Soc Rev       Date:  2020-10-19       Impact factor: 54.564

2.  Discovery of Surfactins as Inhibitors of MicroRNA Processing Using Cat-ELCCA.

Authors:  Andrew W Robertson; Jorge Sandoval; Osama G Mohamed; Yihao Zhuang; Erin E Gallagher; Jennifer Schmidt; Lisa Caratelli; Arya Menon; Pamela J Schultz; Rachel M Torrez; Catherine L Hay; Bailey A Bell; Paul A Price; Amanda L Garner; Ashootosh Tripathi
Journal:  ACS Med Chem Lett       Date:  2021-04-02       Impact factor: 4.632

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.